-
CordenPharma Colorado Increases US Peptide Manufacturing Capacity
contractpharma
November 26, 2020
Long-term expansion initiative approved to further increase flexibility, efficiency and ultimately, cost-effective production.
-
CordenPharma Expands Peptide Development Capacity
contractpharma
November 19, 2020
?CordenPharma’s Centre of Excellence for Peptide Process Development and non-GMP manufacturing in Frankfurt, Germany is not only known for bringing a high level of peptide expertise in the development of efficient and lean peptide processes like ...
-
FDA Grants Orphan Drug Designation for Prosthetic Joint Infections Treatment
americanpharmaceuticalreview
September 14, 2020
Peptilogics has announced that the US Food and Drug Administration (FDA) has granted Orphan Drug Designation for PLG0206, the company's first-in-class, broad-spectrum antibiotic peptide, for the treatment of prosthetic joint infections (PJI) ...
-
CordenPharma Increases U.S. Peptide Manufacturing Capacity
contractpharma
July 09, 2020
Expansion aims to accommodate a large spike in demand for peptide API’s.
-
Novel drug shows promise against acute myeloid leukaemia
europeanpharmaceuticalreview
April 13, 2018
First of a new class of anti-cancer agents to reach clinical trials…
-
Janssen inks mega-deal with Japan’s PeptiDream
pharmatimes
April 12, 2017
Janssen Pharmaceuticals has signed up for access to PeptiDream’s peptide discovery technology in a deal that could be worth $1.15 billion.
ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
Pharma Sources Insight July 2025
